<- Go Home
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Market Cap
$3.9M
Volume
98.9K
Cash and Equivalents
$17.8M
EBITDA
-$13.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$3.04
52 Week Low
$0.56
Dividend
N/A
Price / Book Value
0.23
Price / Earnings
-0.31
Price / Tangible Book Value
0.23
Enterprise Value
-$13.9M
Enterprise Value / EBITDA
1.01
Operating Income
-$13.8M
Return on Equity
53.03%
Return on Assets
-33.21
Cash and Short Term Investments
$17.8M
Debt
N/A
Equity
$17.2M
Revenue
N/A
Unlevered FCF
-$10.5M
Sector
Health Care Equipment and Supplies
Category
N/A